Fifth Third Bancorp
FRTX

Fifth Third Bancorp’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Fifth Third Bancorp’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-556
Closed -$18K – 2818
2021
Q3 		$18K Hold
556
– – ﹤0.01% 1833
2021
Q2 		$24K Hold
556
– – ﹤0.01% 1740
2021
Q1 		$27K Buy
+556
New +$30.5K ﹤0.01% 1670
2016
Q4 		– Hold
0
– – – 2312
2016
Q3 		– Hold
0
– – – 2318
2014
Q1 		– Hold
0
– – – 2385
2013
Q4 		– Hold
0
– – – 2249
2013
Q3 		– Hold
0
– – – 2306
2013
Q2 		– Hold
0
– – – 2190

Other funds holding FRTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fifth Third Bancorp's FRTX Position: Q4 2021 in Review

Fifth Third Bancorp sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2021, closing a stake of 556 shares — an estimated $18K sold.

Fifth Third Bancorp first reported a position in FRTX in Q1 2021 and held it in 3 quarters. The position peaked at $27K in Q1 2021. 30 funds tracked by Wall St. Rank hold FRTX as of Q4 2021.

  • Fifth Third Bancorp reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 556 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $18K.
  • Fifth Third Bancorp first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Fifth Third Bancorp's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $27K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Fifth Third Bancorp's 13F filing for Q4 2021, filed 1 Feb 2022.